PAVmed Inc (STU:1P50)
€ 2.78999 0 (0%) Market Cap: 10.23 Mil Enterprise Value: 35.88 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

Q2 2021 PAVmed Inc Earnings Call Transcript

Aug 12, 2021 / 08:30PM GMT
Release Date Price: €77.29 (+6.03%)
Operator

Greetings, and welcome to the PAVmed Inc. Business Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mike Havrilla, Director of Investor Relations for PAVmed. Please proceed.

Mike Havrilla
PAVmed Inc. - Director of IR

Thanks, operator. Good afternoon, everyone. This is Mike Havrilla, PAVmed's Director of Investor Relations. Thanks for participating in today's business update call. Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer; and Dennis McGrath, President and Chief Financial Officer.

Press release announcing our business updates and financial results is available on PAVmed's website. Please take a moment to read the disclaimer about forward-looking statements in the press release. The business update press release and this conference call both include forward-looking statements. And these forward-looking statements are subject to known and unknown risks and uncertainties, may cause actual results to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot